Xcout Intel
Protara Therapeutics, Inc.
Protara Therapeutics, Inc. is a biotechnology research company headquartered in New York, NY, focused on developing new therapies.
Subscribe to see Protara Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Protara Therapeutics, Inc. at a glance
Protara Therapeutics, Inc. is a drugs company headquartered in New York City, United States. It is publicly listed (TARA) with a market capitalisation of $137.7M. Xcout tracks 19 named people at Protara Therapeutics, Inc., including Patrick Fabbio (Chief Financial Officer). Xcout recorded 9 job postings from Protara Therapeutics, Inc. in the last 90 days.
Protara Therapeutics, Inc. leadership
- Patrick FabbioChief Financial Officer
- Shane WilliamsChief People Officer
- William ConklingChief Commercial Officer
- Jesse SheffermanCo-founder, Chief Executive Officer, President & Director
- Jacqueline ZummoCo-Founder, Chief R&D Officer
- Justine O'MalleySenior Vice President of Investor Relations & Corporate Affairs
13 more named people on record for Protara Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Hiring at Protara Therapeutics, Inc.
Xcout recorded 9 job postings from Protara Therapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Protara Therapeutics, Inc.'s hiring signals →
Protara Therapeutics, Inc. competitors
A few of Protara Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Prazer Therapeutics is a biotechnology company founded in 2019 and headquartered in Seoul, South Korea. The company focuses on developing orally available, brain-penetrating small molecule therapeutics utilizing targeted protein degradation technology for novel drug discovery.
Promontory Therapeutics Inc. is a privately held, clinical-stage pharmaceutical company founded in 2010 and headquartered in New York, NY. The firm focuses on small molecule immunotherapy.
Bridge Medicines LLC is a drug discovery holding company headquartered in New York, NY, that accelerates the path of therapeutic pipelines from research to patients.
Automera is an early-stage biotechnology research company headquartered in Singapore. The company focuses on the development of novel therapeutics through autophagy-based targeted protein degradation.
Cogent Biosciences is a publicly traded biotechnology company headquartered in Waltham, Massachusetts, founded in 2014. The company focuses on developing real solutions and novel treatments for genetically driven diseases.
Get Protara Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Protara Therapeutics, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Protara Therapeutics, Inc. in Xcout Intel
- 19 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access